Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cunningham

Showing results (431-440 of 465) with videos related to

Pageof 47
Sort By:
Journal of Burn Care & Research : Official Publication of the American Burn Association|July 13, 2019
The Interplay of Nutrition, Physical Activity, Severity of Illness, and Mortality in Critically Ill Burn Patients: Is There a Connection?Beth A Shields, Jennifer N Carpenter, Brenda D Bustillos, et al.
Drug and Alcohol Dependence|April 17, 2022
Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatmentAlison D Marshall, Anna Conway, Evan B Cunningham, et al.
Viruses|November 27, 2024
A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage StudyAlison D Marshall, Anna Conway, Evan B Cunningham, et al.
The Lancet. Gastroenterology & Hepatology|March 18, 2022
Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
The International Journal on Drug Policy|December 21, 2022
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
The Lancet. Gastroenterology & Hepatology|May 9, 2021
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort studyBehzad Hajarizadeh, Jason Grebely, Marianne Byrne, et al.
The Lancet. Global Health|March 30, 2023
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic reviewLouisa Degenhardt, Paige Webb, Samantha Colledge-Frisby, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 19, 2017
Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapseFrançois M J Lamoury, Angelica Soker, Danica Martinez, et al.
The International Journal on Drug Policy|June 22, 2017
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE studyHåvard Midgard, Behzad Hajarizadeh, Evan B Cunningham, et al.
The International Journal on Drug Policy|November 3, 2018
Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in AustraliaSahar Bajis, Lisa Maher, Carla Treloar, et al.
Pageof 47

Showing results (431-440 of 465) with videos related to

Sort By:
Pageof 47
Journal of Burn Care & Research : Official Publication of the American Burn Association|July 13, 2019
The Interplay of Nutrition, Physical Activity, Severity of Illness, and Mortality in Critically Ill Burn Patients: Is There a Connection?Beth A Shields, Jennifer N Carpenter, Brenda D Bustillos, et al.
Drug and Alcohol Dependence|April 17, 2022
Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatmentAlison D Marshall, Anna Conway, Evan B Cunningham, et al.
Viruses|November 27, 2024
A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage StudyAlison D Marshall, Anna Conway, Evan B Cunningham, et al.
The Lancet. Gastroenterology & Hepatology|March 18, 2022
Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
The International Journal on Drug Policy|December 21, 2022
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
The Lancet. Gastroenterology & Hepatology|May 9, 2021
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort studyBehzad Hajarizadeh, Jason Grebely, Marianne Byrne, et al.
The Lancet. Global Health|March 30, 2023
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic reviewLouisa Degenhardt, Paige Webb, Samantha Colledge-Frisby, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 19, 2017
Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapseFrançois M J Lamoury, Angelica Soker, Danica Martinez, et al.
The International Journal on Drug Policy|June 22, 2017
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE studyHåvard Midgard, Behzad Hajarizadeh, Evan B Cunningham, et al.
The International Journal on Drug Policy|November 3, 2018
Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in AustraliaSahar Bajis, Lisa Maher, Carla Treloar, et al.
Pageof 47